Cargando…

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review

Hepatocellular carcinoma (HCC) is a major health problem worldwide, affecting more than 600,000 new patients per year. Curative treatments are available in a small percentage of patients, while most of them present in stages requiring locoregional treatments such as thermoablation, transarterial che...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin, Daniel, Cappabianca, Salvatore, Serra, Nicola, Sica, Assunta, Lassandro, Francesco, D'Angelo, Roberto, La Porta, Michelearcangelo, Fiore, Francesco, Somma, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700180/
https://www.ncbi.nlm.nih.gov/pubmed/26798332
http://dx.doi.org/10.1155/2015/670965
_version_ 1782408290249998336
author Marin, Daniel
Cappabianca, Salvatore
Serra, Nicola
Sica, Assunta
Lassandro, Francesco
D'Angelo, Roberto
La Porta, Michelearcangelo
Fiore, Francesco
Somma, Francesco
author_facet Marin, Daniel
Cappabianca, Salvatore
Serra, Nicola
Sica, Assunta
Lassandro, Francesco
D'Angelo, Roberto
La Porta, Michelearcangelo
Fiore, Francesco
Somma, Francesco
author_sort Marin, Daniel
collection PubMed
description Hepatocellular carcinoma (HCC) is a major health problem worldwide, affecting more than 600,000 new patients per year. Curative treatments are available in a small percentage of patients, while most of them present in stages requiring locoregional treatments such as thermoablation, transarterial chemoembolization, and/or radioembolization. These therapies result in specific imaging features that the general radiologist has to be aware of in order to assess the response to treatment and to correctly manage the follow-up of treated patients. Multiphasic helical computed tomography has become a popular imaging modality for detecting hypervascular tumors and characterizing liver lesions. On this basis, many staging and diagnostic systems have been proposed for evaluating response to all different existing strategies. Radiofrequencies and microwaves generate thermoablation of tumors, and transarterial chemoembolization exploits the double effect of the locoregional administration of drugs and embolizing particles. Eventually radioembolization uses a beta-emitting isotope to induce necrosis. Therefore, the aim of this comprehensive review is to analyze and compare CT imaging appearance of HCC after various locoregional treatments, with regard to specific indications for all possible procedures.
format Online
Article
Text
id pubmed-4700180
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-47001802016-01-21 CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review Marin, Daniel Cappabianca, Salvatore Serra, Nicola Sica, Assunta Lassandro, Francesco D'Angelo, Roberto La Porta, Michelearcangelo Fiore, Francesco Somma, Francesco Gastroenterol Res Pract Review Article Hepatocellular carcinoma (HCC) is a major health problem worldwide, affecting more than 600,000 new patients per year. Curative treatments are available in a small percentage of patients, while most of them present in stages requiring locoregional treatments such as thermoablation, transarterial chemoembolization, and/or radioembolization. These therapies result in specific imaging features that the general radiologist has to be aware of in order to assess the response to treatment and to correctly manage the follow-up of treated patients. Multiphasic helical computed tomography has become a popular imaging modality for detecting hypervascular tumors and characterizing liver lesions. On this basis, many staging and diagnostic systems have been proposed for evaluating response to all different existing strategies. Radiofrequencies and microwaves generate thermoablation of tumors, and transarterial chemoembolization exploits the double effect of the locoregional administration of drugs and embolizing particles. Eventually radioembolization uses a beta-emitting isotope to induce necrosis. Therefore, the aim of this comprehensive review is to analyze and compare CT imaging appearance of HCC after various locoregional treatments, with regard to specific indications for all possible procedures. Hindawi Publishing Corporation 2015 2015-12-22 /pmc/articles/PMC4700180/ /pubmed/26798332 http://dx.doi.org/10.1155/2015/670965 Text en Copyright © 2015 Daniel Marin et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Marin, Daniel
Cappabianca, Salvatore
Serra, Nicola
Sica, Assunta
Lassandro, Francesco
D'Angelo, Roberto
La Porta, Michelearcangelo
Fiore, Francesco
Somma, Francesco
CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review
title CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review
title_full CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review
title_fullStr CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review
title_full_unstemmed CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review
title_short CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review
title_sort ct appearance of hepatocellular carcinoma after locoregional treatments: a comprehensive review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700180/
https://www.ncbi.nlm.nih.gov/pubmed/26798332
http://dx.doi.org/10.1155/2015/670965
work_keys_str_mv AT marindaniel ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview
AT cappabiancasalvatore ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview
AT serranicola ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview
AT sicaassunta ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview
AT lassandrofrancesco ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview
AT dangeloroberto ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview
AT laportamichelearcangelo ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview
AT fiorefrancesco ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview
AT sommafrancesco ctappearanceofhepatocellularcarcinomaafterlocoregionaltreatmentsacomprehensivereview